H.R. 5316, known as the Drug Shortage Compounding Patient Access Act of 2025, aims to address the issue of drug shortages in the U.S. by improving access to compounded medications for patients. The bill likely includes measures to streamline the compounding process and enhance the ability of pharmacies to produce necessary medications when commercial products are unavailable.